Australia's Clinuvel Pharma Wins FDA Approval for its Drug

Clinuvel Pharmaceuticals has been granted orphan-drug status for the first time by the US Food and Drug Administration (FDA) for its drug to treat erythropoietic porphyrias.
TradingMarkets.com